Pregnancy and HIV infection: A European consensus on management

AIDS, Supplement

Volumn 16, Issue 2, 2002, Pages

  Newell, Marie Louise ^a   Rogers, Martha ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; AMPRENAVIR; ANTICONVULSIVE AGENT; DELAVIRDINE; DIDANOSINE; EFAVIRENZ; FOLIC ACID; HYDROXYUREA; INDINAVIR; LAMIVUDINE; NELFINAVIR; NEVIRAPINE; RIFABUTIN; RIFAMPICIN; RITONAVIR; SAQUINAVIR; STAVUDINE; SULFONAMIDE; VIRUS RNA; VITAMIN K GROUP; ZALCITABINE; ZIDOVUDINE; ANTIRETROVIRUS AGENT; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ANEMIA; BREAST FEEDING; CESAREAN SECTION; CLINICAL TRIAL; CONFERENCE PAPER; DISEASE COURSE; DRUG SAFETY; EUROPE; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; NEWBORN; PATIENT COUNSELING; PREGNANCY COMPLICATION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PROGNOSIS; TERATOGENICITY; VERTICAL TRANSMISSION; VIRUS LOAD; VIRUS TRANSMISSION; BILE DUCT ATRESIA; BRAIN HEMORRHAGE; CHEMICAL TERATOGENESIS; CONGENITAL GLAUCOMA; CONSENSUS DEVELOPMENT; DIAGNOSTIC IMAGING; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG MONITORING; ELECTIVE SURGERY; HETEROSEXUALITY; INFECTION PREVENTION; INFECTION RATE; INFECTION RISK; MONOTHERAPY; PATIENT CARE; PATIENT MONITORING; PREGNANCY; RISK ASSESSMENT; SECOND TRIMESTER PREGNANCY; SEXUAL BEHAVIOR; TREATMENT CONTRAINDICATION; ANTIBIOTIC RESISTANCE; CHILD; CHILD WELFARE; CONTRACEPTION; COUNSELING; DISEASE TRANSMISSION; DRUG RESISTANCE; HEALTH STATUS; INFANT NUTRITION; MATERNAL CARE; METHODOLOGY; PATIENT COMPLIANCE; POSTNATAL CARE; PRENATAL CARE;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BREAST FEEDING; CESAREAN SECTION; CHILD; CHILD WELFARE; CONTRACEPTION; COUNSELING; DISEASE TRANSMISSION, VERTICAL; DRUG RESISTANCE; DRUG RESISTANCE, VIRAL; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS; HIV INFECTIONS; HUMAN; INFANT NUTRITION; INFANT, NEWBORN; PATIENT COMPLIANCE; POSTNATAL CARE; PRECONCEPTION CARE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL CARE; ZIDOVUDINE; HUMANS; INFANT NUTRITION PHYSIOLOGY;

EID: 0012565358     PISSN: 13502840     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (38)

1. HIV-infected pregnant women and vertical transmission in Europe since 1986
2. Mechanisms and timing of mother-to-child transmission of HIV-1
3. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment
4. 6-Month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Cote d'lvoire and Burkina Faso: A double-blind placebo controlled multicentre trial
5. Report of results of PACTG 316: An international phase III trial of standard antiretroviral prophylaxis plus nevirapine for prevention of perinatal HIV transmission
6. Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus
7. Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Cote d'lvoire: A randomised trial
8. A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1
9. Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women
10. Perinatal HIV-1 transmission: Interaction between zidovudine prophylaxis and mode of delivery in the French Perinatal Cohort
11. Elective caesarean section versus vaginal delivery in prevention of vertical HIV-1 transmission: A randomised clinical trial
12. Mode of delivery and vertical transmission of HIV-1: A meta-analysis from fifteen prospective cohort studies
13. Combination antiretroviral therapy and duration of pregnancy
14. Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads <1000 copies/ml
15. Combination antiretroviral strategies for the treatment of pregnant HIV-1 infected women and prevention of perinatal HIV-1 transmission
16. Prevention of vertical HIV transmission: Additive protective effect of elective Caesarean section and zidovudine prophylaxis
17. Maternal viral load and vertical transmission of HIV-1: An important factor but not the only one
18. The cost-effectiveness of elective cesarean delivery for HIV-infected women with detectable HIV RNA during pregnancy
19. Cost-effectiveness of cesarean section delivery to prevent mother-to-child transmission of HIV-1
20. The incidence of complications after caesarean section in 156 HIV-positive women
21. Duration of ruptured membranes and vertical transmission of HIV-1: A meta-analysis from 15 prospective cohort studies
22. Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1
23. Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa and Uganda (Petra Study): A randomised, double-blind, placebo-controlled trial
24. Prophylaxis against HIV-1 infection in chimpanzees by nevirapine, nonnucleoside inhibitor of reverse transcriptase
25. Antiretroviral therapies in pregnancy: Maternal, fetal and neonatal effects
26. Absence of cardiac toxicity of zidovudine in infants
27. Maternal viral genotypic zidovudine resistance and infrequent failure of zidovudine therapy to prevent perinatal transmission of human immunodeficiency virus type 1 in pediatric AIDS Clinical Trials Group Protocol 076
28. Antiretroviral drug resistance testing in adults with HIV infection
29. Clinical and laboratory guidelines for the use of HIV-1 drug resistance testing as part of treatment management: Recommendations for the European setting
30. Two to four weeks oral maternal and 10 days intravenous neonatal zidovudine prophylaxis and elective caesarean section: Effective and safe in reducing vertical transmission of HIV-1 infection
31. Zidovudine pharmacokinetics in premature infants exposed to HIV
32. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: A randomised controlled trial
33. Method of feeding and transmission of HIV-1 from mothers to children by 15 months of age: Prospective cohort study from Durban, South Africa
34. Lack of tumors in infants with perinatal HIV-1 exposure and fetal/neonatal exposure to zidovudine
35. Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues
36. Nucleoside exposure in the children of HIV-infected women receiving antiretroviral drugs: Absence of clear evidence for mitochondiral disease in children who died before 5 years of age in five United States cohorts